Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
Rewinds
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Search
Friday, January 24, 2020
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Teprotumumab may significantly improve outcomes in patients with active thyroid eye…
Transgender adults who received puberty suppression report lower suicidal ideation
Pediatric discharge transition survey demonstrates congruence with other validated tools
Classics™
Rewinds
2 Minute Medicine Rewind December 30, 2019
2 Minute Medicine Rewind December 23, 2019
2 Minute Medicine Rewind December 9, 2019
2 Minute Medicine Rewind December 2, 2019
2 Minute Medicine Rewind November 25, 2019
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Tag: CFTR modulator
Elexacaftor-tezacaftor-ivacaftor is efficacious in treating cystic fibrosis patients with Phe508del-minimal function...
Thomas Su
-
November 15, 2019
0
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
